Monitoring heart failure patients through voice analysis
A Pilot Study on AI-Based Voice Analysis for Monitoring Patients Hospitalized With Acute Decompensated Heart Failure
This study is testing if daily voice recordings from heart failure patients in the hospital can help spot signs of their condition getting worse.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 70 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Noah Labs Industry-sponsored |
| Locations | 2 sites (Rochester, Minnesota and 1 other locations) |
| Trial ID | NCT06566911 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients with acutely decompensated heart failure at two sites in the United States and Germany. Participants will record their voices daily during their hospital stay, from admission to discharge, while additional clinical data such as left ventricular ejection fraction and NTpro-BNP levels will be collected. The aim is to identify voice-based indicators that could signal heart failure progression, potentially improving remote monitoring and self-management for these patients.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have been clinically diagnosed with acutely decompensated heart failure.
Not a fit: Patients with disabling mental diseases, chronic obstructive pulmonary disease, or those requiring intensive care treatment may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to more effective monitoring and management strategies for heart failure patients.
How similar studies have performed: While voice analysis for health monitoring is an emerging field, this specific approach in heart failure is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinically diagnosed with Acutely Decompensated Heart Failure. * At least 18 years of age. Exclusion criteria: * Disabling mental diseases (e.g., Alzheimer's disease) * Clinically diagnosed chronic obstructive pulmonary disease (COPD) * Treatment in ICU or IMU * Dialysis treatment * Previous operations on organs involved in generation of voice (vocal tract, vocal folds, etc.) * Neurodegenerative diseases * Pregnancy * Inability to provide consent
Where this trial is running
Rochester, Minnesota and 1 other locations
- Mayo Clinic — Rochester, Minnesota, United States (Recruiting)
- Deutsches Herzzentrum der Charité — Berlin, Germany (Completed)
Study contacts
- Principal investigator: Gerhard Hindricks, MD — German Heart Institute
- Study coordinator: Leonhard Riehle, MD
- Email: leonhard.riehle@noah-labs.com
- Phone: +49 32 221093495
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.